Dario Gregori

Prof. Dr. Dario Gregori

Unit of Biostatistics, Epidemiology and Public Health, DCTVPH, University of Padova, Padua 35121, Italy
+1
orcid

Research Focus & Metrics

Academic Career Length

33Years (1994-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 July 1999 in JACC
Verified
Journal Article
Closed access
LMLuisa Mestroni
Luisa Mestroni
CRChiara Rocco
Chiara Rocco
Dario GregoriDario Gregori
Dario Gregori
GSGianfranco Sinagra
Gianfranco Sinagra
ALAndrea Di Lenarda
Andrea Di Lenarda
FCFulvio Camerini
Fulvio Camerini

19 August 2004 in British Journal of Surgery
Verified
Journal Article
Closed access
PDF file
GCGábor Cserni
Gábor Cserni
Dario GregoriDario Gregori
Dario Gregori
FMF. Merletti
F. Merletti
Anna SapinoAnna Sapino
Anna Sapino
MMMaria Piera Mano
Maria Piera Mano
GBG. Bussolati
G. Bussolati

1 December 2013 in Circulation: Cardiovascular Genetics
Verified
Journal Article
Closed access
PDF file
IRIlaria Rigato
Ilaria Rigato
BBBarbara Bauce
Barbara Bauce
ARAlessandra Rampazzo
Alessandra Rampazzo
Alessandro ZorziAlessandro Zorzi
Alessandro Zorzi
KPKalliopi Pilichou
Kalliopi Pilichou
DCDomenico Corrado
Domenico Corrado
Background—: Mutations in genes encoding for desmosomal proteins are the most common cause of arrhythmogenic right ventricular cardiomyopathy (ARVC). We assessed the value of genotype for prediction of lifetime major arrhythmic events and sudden cardiac death (SCD) in desmosomal gene–related ARVC. Methods and Results—: The overall study population included 134 desmosomal gene mutation carriers (68 men; median age 36 years [22–52]) from 44 consecutive ARVC families undergoing comprehensive genetic screening. The probability of experiencing a first major arrhythmic event or SCD during a lifetime was determined by using date of birth as start point for the time-to-event analysis, and was stratified by sex, desmosomal genes, mutation types, and genotype complexity (single versus multiple mutations). One hundred thirteen patients (84%) carried a single desmosomal gene mutation in desmoplakin (n=44; 39%), plakophilin-2 (n=38; 34%), desmoglein-2 (n=30; 26%), and desmocollin-2 (n=1; 1%), whereas 21 patients (16%) had a complex genotype with compound heterozygosity in 7 and digenic heterozygosity in 14. Over a median observation period of 39 (22–52) years, 22 patients (16%) from 20 different families had arrhythmic events, such as SCD (n=1), aborted SCD because of ventricular fibrillation (n=6), sustained ventricular tachycardia (n=14), and appropriate defibrillator intervention (n=1). Multiple desmosomal gene mutations and male sex were independent predictors of lifetime arrhythmic events with a hazard ratio of 3.71 (95% confidence interval, 1.54–8.92; P =0.003) and 2.76 (95% confidence interval, 1.19–6.41; P =0.02), respectively. Conclusions—: Compound/digenic heterozygosity was identified in 16% of ARVC-causing desmosomal gene mutation carriers and was a powerful risk factor for lifetime major arrhythmic events and SCD. These results support the use of comprehensive genetic screening of desmosomal genes for arrhythmic risk stratification in ARVC.

3 March 2008 in Archives of Facial Plastic Surgery
Verified
Journal Article
Closed access
EGEzio Nicola Gangemi
Ezio Nicola Gangemi
Dario GregoriDario Gregori
Dario Gregori
Paola BerchiallaPaola Berchialla
Paola Berchialla
EZEnrico Zingarelli
Enrico Zingarelli
MCMonica Cairo
Monica Cairo
MSMaurizio Stella
Maurizio Stella
Objective: To describe the clinical characteristics of postburn scars and determine the independent risk factors specific to these patients. While burns may generate widespread and disfiguring scars and have a dramatic influence on patient quality of life, the prevalence of postburn pathologic scarring is not well documented, and the impact of certain risk factors is poorly understood. Methods: A retrospective analysis was conducted of the clinical records of 703 patients (2440 anatomic burn sites) treated at the Turin Burn Outpatient Clinic between January 1994 and May 15, 2006. Prevalence and evolution time of postburn pathologic scarring were analyzed with univariate and multivariate risk factor analysis by sex, age, burn surface and full-thickness area, cause of the burn, wound healing time, type of burn treatment, number of surgical procedures, type of surgery, type of skin graft, and excision and graft timing. Results: Pathologic scarring was diagnosed in 540 patients (77%): 310 had hypertrophic scars (44%); 34, contractures (5%); and 196, hypertrophic-contracted scars (28%). The hypertrophic induction was assessed at a median of 23 days after reepithelialization and lasted 15 months (median). A nomogram, based on the multivariate regression model, showed that female sex, young age, burn sites on the neck and/or upper limbs, multiple surgical procedures, and meshed skin grafts were independent risk factors for postburn pathologic scarring (D xy 0.30). Conclusion: The identification of the principal risk factors for postburn pathologic scarring not only would be a valuable aid in early risk stratification but also might help in assessing outcomes adjusted for patient risk.

1 October 2006 in JACC
Verified
Journal Article
Closed access
PSPedro Silva-Orrego
Pedro Silva-Orrego
PCPaola Colombo
Paola Colombo
RBRiccardo Bigi
Riccardo Bigi
Dario GregoriDario Gregori
Dario Gregori
ADAnabella Delgado
Anabella Delgado
SKSilvio Klugmann
Silvio Klugmann

1 April 2010 in Drug and Alcohol Dependence
Verified
Journal Article
Closed access
FFFabrizio Faggiano
Fabrizio Faggiano
FVFederica Vigna-Taglianti
Federica Vigna-Taglianti
GBGregor Burkhart
Gregor Burkhart
KBKarl Bohrn
Karl Bohrn
LCLuca Cuomo
Luca Cuomo
MGMaria Rosaria Galanti
Maria Rosaria Galanti